CN101375157B - 用于治疗涉及对肺中存在的结缔组织自身免疫反应的肺病的分子 - Google Patents

用于治疗涉及对肺中存在的结缔组织自身免疫反应的肺病的分子 Download PDF

Info

Publication number
CN101375157B
CN101375157B CN200780003133.2A CN200780003133A CN101375157B CN 101375157 B CN101375157 B CN 101375157B CN 200780003133 A CN200780003133 A CN 200780003133A CN 101375157 B CN101375157 B CN 101375157B
Authority
CN
China
Prior art keywords
col
lung
collagen
transplantation
allograft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780003133.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN101375157A (zh
Inventor
D·S·威尔克斯
M·J·克莱门兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indiana University Research and Technology Corp
Original Assignee
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indiana University Research and Technology Corp filed Critical Indiana University Research and Technology Corp
Publication of CN101375157A publication Critical patent/CN101375157A/zh
Application granted granted Critical
Publication of CN101375157B publication Critical patent/CN101375157B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rehabilitation Therapy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CN200780003133.2A 2006-01-13 2007-01-13 用于治疗涉及对肺中存在的结缔组织自身免疫反应的肺病的分子 Expired - Fee Related CN101375157B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75919506P 2006-01-13 2006-01-13
US60/759,195 2006-01-13
PCT/US2007/060533 WO2007120947A1 (en) 2006-01-13 2007-01-13 Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung

Publications (2)

Publication Number Publication Date
CN101375157A CN101375157A (zh) 2009-02-25
CN101375157B true CN101375157B (zh) 2015-06-17

Family

ID=38609836

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780003133.2A Expired - Fee Related CN101375157B (zh) 2006-01-13 2007-01-13 用于治疗涉及对肺中存在的结缔组织自身免疫反应的肺病的分子

Country Status (8)

Country Link
US (3) US7759075B2 (enExample)
EP (2) EP1977234B1 (enExample)
JP (2) JP5030973B2 (enExample)
CN (1) CN101375157B (enExample)
AU (1) AU2007238533C1 (enExample)
BR (1) BRPI0706575B8 (enExample)
CA (2) CA2641318C (enExample)
WO (1) WO2007120947A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1977234B1 (en) * 2006-01-13 2015-11-04 Indiana University Research & Technology Corporation Type V collagen for use in a method of treatment of idiopathic pulmonary fibrosis
EP2120967B1 (en) * 2006-11-28 2015-10-21 University Of Southern California Method for promoting wound healing
JP2012518001A (ja) * 2009-02-13 2012-08-09 インディアナ ユニバーシティ リサーチ アンド テクノロジー コーポレイション Ｍｍｐ２およびｍｍｐ９を阻害する化合物および方法
KR101815716B1 (ko) * 2009-04-22 2018-01-05 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 만성 폐쇄성 폐 질환 및 천식의 치료에 사용하기 위한 조성물
GB2488289A (en) 2009-11-06 2012-08-22 Univ Leland Stanford Junior Non-invasive diagnosis of graft rejection in organ transplant patients
CA2856798A1 (en) * 2011-05-31 2012-12-06 Idexx Laboratories, Inc. Detection of degradation products of feline nt-probnp
RU2014139546A (ru) * 2012-03-27 2016-05-20 Дженентек, Инк. Методы прогнозирования, диагностики и лечения идиопатического легочного фиброза
JP6058354B2 (ja) * 2012-11-02 2017-01-11 東芝メディカルシステムズ株式会社 画像処理装置及び画像処理方法
JP6312054B2 (ja) * 2013-11-06 2018-04-18 学校法人日本大学 間質性肺炎のバイオマーカー
US20170082619A1 (en) 2015-09-23 2017-03-23 One Lambda, Inc. Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
CN1227565A (zh) * 1996-06-05 1999-09-01 生物分子研究所有限公司 结构与呼吸道合胞体病毒的g蛋白同源的病毒肽
CN1406248A (zh) * 2000-01-31 2003-03-26 旭化成株式会社 肺炎衣原体检测用抗体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487289B1 (en) 1990-11-20 1996-09-04 BEHRINGWERKE Aktiengesellschaft Cyclosporin immunoassay
US6911220B1 (en) 1992-02-19 2005-06-28 The General Hospital Corporation Allogeneic and xenogeneic transplantation
JP2702354B2 (ja) * 1992-05-11 1998-01-21 帝人株式会社 血中の肺組織障害マーカー
US5778875A (en) * 1996-05-06 1998-07-14 U.S. Divers Co., Inc. First stage regulator and rotatable in-line valve
US5962025A (en) 1996-07-16 1999-10-05 The University Of Tennessee Research Corporation Method for treatment of systemic sclerosis and related fibrotic diseases
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US7348005B2 (en) 2000-03-15 2008-03-25 Advanced Research And Technology Institute Oral tolerance induction by collagen to prevent allograft rejection
BR0109455A (pt) * 2000-03-23 2003-06-03 Akzo Nobel Nv Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos
JP2002220343A (ja) * 2001-01-26 2002-08-09 Toray Ind Inc びまん性肺疾患延命剤
US20050227297A1 (en) * 2004-04-08 2005-10-13 D Andrea Michael R Method for immunohistochemical detection of collagen in a tissue sample
KR20080073747A (ko) 2005-11-16 2008-08-11 유니버시티 오브 테네시 리서치 파운데이션 면역내성의 유도에 의한 섬유화 질환의 치료방법
EP1977234B1 (en) * 2006-01-13 2015-11-04 Indiana University Research & Technology Corporation Type V collagen for use in a method of treatment of idiopathic pulmonary fibrosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
CN1227565A (zh) * 1996-06-05 1999-09-01 生物分子研究所有限公司 结构与呼吸道合胞体病毒的g蛋白同源的病毒肽
CN1406248A (zh) * 2000-01-31 2003-03-26 旭化成株式会社 肺炎衣原体检测用抗体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
felix fernandez-madrid et al..Autoimmunity to collagen in human lung cancer.《cancer research》.1996,第56卷第121页-第126页. *

Also Published As

Publication number Publication date
US8039225B2 (en) 2011-10-18
EP2672266A3 (en) 2014-02-05
CA2965211C (en) 2020-06-30
EP2672266A2 (en) 2013-12-11
AU2007238533B2 (en) 2012-09-20
JP5030973B2 (ja) 2012-09-19
CA2641318A1 (en) 2007-10-25
EP1977234A1 (en) 2008-10-08
EP1977234B1 (en) 2015-11-04
HK1126861A1 (en) 2009-09-11
JP2012108137A (ja) 2012-06-07
CA2965211A1 (en) 2007-10-25
US20110183356A1 (en) 2011-07-28
BRPI0706575B8 (pt) 2021-05-25
US20110020838A1 (en) 2011-01-27
EP1977234A4 (en) 2009-06-03
BRPI0706575A2 (pt) 2011-04-05
AU2007238533C1 (en) 2013-08-15
BRPI0706575B1 (pt) 2018-12-11
JP5936349B2 (ja) 2016-06-22
US20090017013A1 (en) 2009-01-15
US7939281B2 (en) 2011-05-10
CN101375157A (zh) 2009-02-25
CA2641318C (en) 2017-06-20
WO2007120947A1 (en) 2007-10-25
AU2007238533A1 (en) 2007-10-25
JP2009524023A (ja) 2009-06-25
EP2672266B1 (en) 2018-08-01
US7759075B2 (en) 2010-07-20

Similar Documents

Publication Publication Date Title
CN101375157B (zh) 用于治疗涉及对肺中存在的结缔组织自身免疫反应的肺病的分子
US11884727B2 (en) Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
Yasufuku et al. Oral tolerance induction by type V collagen downregulates lung allograft rejection
JP2006512396A (ja) 免疫寛容を誘導および維持する方法
CN102458446B (zh) 用于治疗慢性阻塞性肺病和哮喘的组合物和方法
HK1126861B (en) Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung
US7348005B2 (en) Oral tolerance induction by collagen to prevent allograft rejection
WO2019077143A1 (en) METHODS AND COMPOSITIONS FOR PREDICTING AND PRECOCUALLY DIAGNOSING A CHRONIC ACTIVE FORM OF ABMR WITH GRAFT GLOMERULOPATHY AND RENAL TRANSPLANT LOSS
CA2402489C (en) Oral tolerance induction by collagen to prevent allograft rejection
Wemlinger Anti-Human CD79 Therapeutic Monoclonal Antibodies: Induction of B Cell Anergy and Translational Studies for Prospective Use in the Treatment of Human Autoimmune Disease
WO2019163838A1 (ja) 多発性硬化症マーカー

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1126861

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1126861

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150617